Akademisyen
ŞULE AYDIN TÜRKOĞLU
PROFESÖR
BOLU ABANT İZZET BAYSAL ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Nöroloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 93
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
13
Q2
17
Q3
19
Q4
9
WoS (JCR)
Q1
7
Q2
10
Q3
13
Q4
24
TR Index
22
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
5
Ort. yüzdelik
48.3%
Üst %1 payı
0.0%
Üst %10 payı
6.4%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Efficacy of immersive virtual reality-based self-managed naming therapy for chronic post-stroke aphasia: A randomized controlled trial YÖKSİS SJR Q1 JCR Q1 OpenAlex 32.8%
- 2026 Cerebrospinal fluid HOXB3 does not differentiate relapsing–remitting multiple sclerosis from idiopathic intracranial hypertension: a pilot study YÖKSİS OpenAlex üst %10 OpenAlex 92.2%
- 2025 Nogo-A and NfL Levels in CSF from Newly Diagnosed Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients Positive for Anti-HHV6-A IgG Autoantibody YÖKSİS SJR Q2 JCR Q1 OpenAlex 22.6%
- 2025 CXCL13 levels in cerebrospinal fluid in relapsing-remitting multiple sclerosis: The role of Borrelia in neuroinfections YÖKSİS SJR Q3 JCR Q3 OpenAlex 64.0%
- 2025 Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis YÖKSİS SJR Q2 JCR Q3 OpenAlex 16.5%
- 2025 Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis YÖKSİS SJR Q2 JCR Q3 OpenAlex 22.3%
- 2025 Trends and global productivity in artificial intelligence research in clinical neurology and neuroimaging: a bibliometric analysis from 1980 to 2024 YÖKSİS SJR Q1 JCR Q3 OpenAlex 71.2%
- 2025 Vestibüler Migren Tedavisinde Büyük Oksipital Sinir Blokajı: Yanlış Tanıdan Etkili Tedaviye YÖKSİS TR Index OpenAlex 32.8%
- 2024 Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.5%
- 2024 The effect of the HMGB1/RAGE/TLR4/NF‐κB signalling pathway in patients with idiopathic epilepsy and its relationship with toxoplasmosis YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.6%
- 2024 Recurring disease activity in relapsing remitting multiple sclerosis: The multicenter RDA-RMS study YÖKSİS SJR Q1 JCR Q2 OpenAlex 77.4%
- 2024 Paroxysmal sympathetic hyperactivity syndrome after recurrent stroke: A case report YÖKSİS OpenAlex 29.2%
- 2024 Does cerebrospinal fluid IL-17F distinguish normal pressure hydrocephalus from dementia? YÖKSİS OpenAlex 0.7%
- 2024 Is increased activator protein 1 in cerebrospinal fluid as a potential biomarker that distinguishes idiopathic intracranial hypertension from multiple sclerosis? YÖKSİS SJR Q3 JCR Q2 OpenAlex 75.5%
- 2023 The incidence of deep venous thrombosis in Parkinson’s disease YÖKSİS SJR Q2 JCR Q3 OpenAlex 86.1%
- 2023 Clinical and Demographic Characteristics of 508 Multiple Sclerosis Patients Using Fingolimod (Vintor) Treatment (Two-Year Efficacy and Reliability Data) YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 43.9%
- 2022 EXAMINATION OF THE EFFECT OF COMORBID DISEASES AND VITAMIN LEVELS ON SLEEP QUALITY YÖKSİS TR Index OpenAlex 0.8%
- 2022 Are We Aware of the Neurological Manifestations of Cytomegalovirus Infection in Immunocompetent Individuals? YÖKSİS SJR Q3 JCR Q4 OpenAlex 43.6%
- 2021 Evaluation of epicardial fat tissue thickness in patients with multiple sclerosis YÖKSİS TR Index OpenAlex 0.3%
- 2021 Comparison of Lower Urinary System Symptoms of Women with Multiple Sclerosis and Healthy YÖKSİS TR Index OpenAlex 60.8%